CSIA Services

  1. Home
  2. Services
  3. Safety Management (Pharmacovigilance)

Safety Management (Pharmacovigilance)

Our delegation is to ensure the safety and reliability of pharmaceutical products, medical devices, quasi–drugs, cosmetics, regenerative medicine products, etc.


We provide services / support for safety management: consultations for safety management prior to conduction of clinical trial, gathering safety information during clinical trial, and management of post-marketing safety information, etc.
Flexible services are provided to short and long term duties in order to satisfy sponsors’ needs.


  • Preparing of electronic report (draft) etc., to regulatory athorities in each region.
  • Preparing of notification in writing (draft) to Investigator and head of the study sites.
  • Preparing of periodic report (draft), drug reexamination report (draft) and treatment outcome report (draft).
  • Coding (MedDRA), Database entry, SGML creation, CIOMS writing, adverse event report writing, translation (English ⇔ Japanese)
    Both for on–site/ off–site
  • Medical evaluation by medical experts (consulting by our contract specialist physician and creation (draft) of written opinion of reporting entity).
  • Quasi–drugs / cosmetics adverse reaction report.
  • Seminars about newly amended system for reporting adverse reactions of Cosmetics/ Quasi drugs.
  • Preparing of DSUR.